IL13 and Alzheimer disease: For European–American AD type, there is a common knowledge regarding interleukins of type 2 inflammation, especially IL-4 and IL-13, as responsible factors for the disease, causing epithelial barrier dysfunction, allergic inflammation, microbiota dysregulation, and natural dermal antimicrobial peptide dysfunction.